Synchron Raises $200M in Series D Round

Why It Matters

The infusion of $200 million accelerates market entry for a surgery‑free BCI that could transform care for paralysis patients, positioning Synchron at the forefront of a nascent, high‑growth neurotech sector.

Deal Summary

Synchron, a leader in non‑surgical brain‑computer interface technology, announced a $200 million Series D financing. The round was led by Double Point Ventures and included existing backers and new investors such as the Australian National Reconstruction Fund and Qatar Investment Authority, bringing total funding to $345 million.